Clinical Trial

Akyva First In Human

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to check if the study device, the Akyva System, is safe to use and to find out if it has any possible side effects. Researchers will see if the study device can help you urinate without the need for catheterization, which involves passing a catheter (small tube) into the bladder, and if there is improvement in the leftover urine amount in your bladder after urinating or trying to urinate.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-20
Trial Details
NCT Number NCT06956209
Lead Sponsor Iota Biosciences, Inc
Collaborators: Astellas Pharma Inc, H&A LifeSciences Pty Ltd
Conditions Underactive Bladder
Enrollment 15 participants
Start Date 2025-09-24
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-15